Context Capital Management’s Tevogen Inc. Warrant TVGNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.52K Hold
97,250
﹤0.01% 406
2026
Q1
$3.3K Hold
97,250
﹤0.01% 376
2025
Q4
$3.73K Hold
97,250
﹤0.01% 308
2025
Q3
$5.4K Hold
97,250
﹤0.01% 254
2025
Q2
$6.8K Hold
97,250
﹤0.01% 233
2025
Q1
$5.24K Hold
97,250
﹤0.01% 188
2024
Q4
$5.25K Hold
97,250
﹤0.01% 198
2024
Q3
$1.25K Hold
97,250
﹤0.01% 274
2024
Q2
$1.9K Sell
97,250
-1,000
-1% -$47 ﹤0.01% 214
2024
Q1
$8.1K Hold
98,250
﹤0.01% 205
2023
Q4
$3.93K Hold
98,250
﹤0.01% 217
2023
Q3
$5K Hold
98,250
﹤0.01% 247
2023
Q2
$4K Hold
98,250
﹤0.01% 263
2023
Q1
$8K Hold
98,250
﹤0.01% 273
2022
Q4
$1K Hold
98,250
﹤0.01% 422
2022
Q3
$12K Hold
98,250
﹤0.01% 459
2022
Q2
$16K Sell
98,250
-1,700
-2% -$401 ﹤0.01% 479
2022
Q1
$27K Buy
+99,950
New +$37.2K ﹤0.01% 552

Other funds holding TVGNW

Context Capital Management's TVGNW Position: Q2 2026 in Review

Context Capital Management held its Tevogen Inc. Warrant (TVGNW) position steady in Q2 2026 at 97,250 shares worth $5.52K. The position accounts for ﹤0.01% of the portfolio, ranked #406.

Context Capital Management first reported a position in TVGNW in Q1 2022 and has held it in 18 quarters since. The position peaked at $27K in Q1 2022. 3 funds tracked by Wall St. Rank hold TVGNW as of Q2 2026.

  • Context Capital Management held 97,250 shares of Tevogen Inc. Warrant worth $5.52K as of Q2 2026.
  • Context Capital Management left its Tevogen Inc. Warrant share count unchanged in Q2 2026.
  • Tevogen Inc. Warrant made up ﹤0.01% of Context Capital Management's portfolio in Q2 2026, its #406 holding.
  • Context Capital Management first reported a position in Tevogen Inc. Warrant in Q1 2022 and has held it in 18 quarters since.
  • Context Capital Management's Tevogen Inc. Warrant position peaked at $27K in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Tevogen Inc. Warrant as of Q2 2026.

Based on Context Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.